$PFE Recent News Stay tuned for more drama in

New Post Public Reply Private Reply Replies (0) Message Board

May 28, 2014 at 10:29 AM

$PFE Recent News

Stay tuned for more drama in Pfizer-AstraZeneca saga, analysts say 3:15 p.m. May 27, 2014 - blogs.marketwatch.com
U.K. stocks up as InterContinental jumps amid bid talk 12:52 p.m. May 27, 2014 - Carla Mozee
European stocks gain, but AstraZeneca slumps 12:18 p.m. May 27, 2014 - Carla Mozee
Is the fate of the stock market in the IRS’s hands? 11:33 a.m. May 27, 2014 - Simon Constable
Newscast: Wall Street continues to gain ground 9:58 a.m. May 27, 2014 - MarketWatch
Newscast: Pfizer walks away from AstraZeneca 7:31 a.m. May 27, 2014 - MarketWatch
Pfizer walks away from AstraZeneca deal 4:02 a.m. May 27, 2014 - Geoffrey Rogow
AstraZeneca boosts FTSE 100 after two days in red 12:28 p.m. May 21, 2014 - Sara Sjolin
AstraZeneca shares creep back up amid urges to reconsider Pfizer deal 12:15 p.m. May 21, 2014 - blogs.marketwatch.com
5 value stocks for investors who fear the worst 10:14 a.m. May 21, 2014 - Philip van Doorn
The best thing about Pfizer’s failure with AstraZeneca 4:00 a.m. May 21, 2014 - Matthew Lynn
U.S. stocks gain as Apple, Russell 2000 rise 1% 5:03 p.m. May 19, 2014 - Anora Mahmudova
Newscast: Stocks open week with a win 4:33 p.m. May 19, 2014 - MarketWatch
Apple reclaims $600 mark; AT&T down on DirecTV deal 3:37 p.m. May 19, 2014 - Saumya Vaishampayan
Stocks rise for second day; small-caps, tech lead: Stock market live blog recap 3:31 p.m. May 19, 2014 - blogs.marketwatch.com
Who can afford AstraZeneca's asking price? Not many, analysts say 2:18 p.m. May 19, 2014 - blogs.marketwatch.com
Investors welcome Pfizer's latest rejection 12:34 p.m. May 19, 2014 - MarketWatch
FTSE 100 yanked lower by AstraZeneca, miners 12:31 p.m. May 19, 2014 - Sara Sjolin
AstraZeneca weighs on Stoxx 600 after rebuffing Pfizer 12:20 p.m. May 19, 2014 - Sara Sjolin
Newscast: Wall Street opens on a mixed note 9:58 a.m. May 19, 2014 - MarketWatch

Pfizer a Buy as it Drops Pursuit of AstraZeneca 8 min ago - Barrons.com
Pfizer Couldn't Get Its Bid Up, Shareholders Should Take Profits 7:31 a.m. Today - Seeking Alpha
Sanofi to sell Cialis OTC 7:16 a.m. Today - Seeking Alpha
Cramer's Mad Money - Father Versus Son (5/27/14) 6:23 a.m. Today - Seeking Alpha
Lilly Strikes Licensing Deal With Sanofi for Over-the-Counter Cialis 12:06 a.m. Today - The Wall Street Journal Interactive Edition
3 Top Dow Dogs Drum 13.5% To 17.4% May Upsides 11:14 p.m. May 27, 2014 - Seeking Alpha
S&P 500 Closes at Record 6:45 p.m. May 27, 2014 - The Wall Street Journal Interactive Edition
S&P 500 Jumps to Record High on Improving Consumer Confidence 4:21 p.m. May 27, 2014 - TheStreet.com
Why Jim Cramer Says Buy Pinnacle Foods (PF) But Avoid AstraZeneca (AZN) Stock 2:15 p.m. May 27, 2014 - TheStreet.com
Pfizer’s Real Issue: Identity Crisis Against Peers 1:03 p.m. May 27, 2014 - 247WallSt.com
Dow Today: Pfizer (PFE) Higher 1:00 p.m. May 27, 2014 - TheStreet.com
Pfizer Decides AstraZeneca Isn’t Worth the Trouble — for Now 12:51 p.m. May 27, 2014 - Wall St. Cheat Sheet
The Future According to Google 11:04 a.m. May 27, 2014 - FOXBusiness
Why Pfizer (PFE) Stock Is Up Today 11:00 a.m. May 27, 2014 - TheStreet.com
Pfizer Pulls Out of AstraZeneca Deal - Analyst Blog 10:35 a.m. May 27, 2014 - Zacks.com
Pfizer Abandons Bid for AstraZeneca 10:01 a.m. May 27, 2014 - TheStreet.com
Pfizer Walks Away, AstraZeneca Shares Fall 9:40 a.m. May 27, 2014 - FOXBusiness
Pfizer Not Better Off After AstraZeneca Exit 9:36 a.m. May 27, 2014 - Seeking Alpha
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. May 27, 2014 - Zacks.com
Wall Street Strikes New High on Data, EU Optimism 7:28 a.m. May 27, 2014 - FOXBusiness

ACETO Subsidiary, Rising Pharmaceuticals, Has Launched the Generic Version of Pfizer Inc.'s Diflucan(R) 4:06 p.m. May 27, 2014 - GlobeNewswire
Must Watch News: Pfizer Inc, AT&T, Alpha Natural Resources, Sprint Corporation 9:06 a.m. May 27, 2014 - ACCESSWIRE
Pfizer BringsFrequent Heartburn ReliefOver-the-Counter with New Nexium® 24HR 8:31 a.m. May 27, 2014 - BusinessWire - BZX
Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics 7:20 a.m. May 27, 2014 - PR Newswire - PRF
Statement from Pfizer Inc. 10:05 a.m. May 26, 2014 - BusinessWire - BZX
Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis 9:13 a.m. May 23, 2014 - BusinessWire - BZX
BioRestorative Therapies Signs Research Agreement with Pfizer Inc. 8:01 a.m. May 22, 2014 - BusinessWire - BZX
Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019 11:59 a.m. May 21, 2014 - PR Newswire - PRF
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014 11:40 a.m. May 21, 2014 - PR Newswire - PRF
New Survey Highlights The Impact Of Menopausal Symptoms On Women In The Workplace 8:15 a.m. May 21, 2014 - BusinessWire - BZX
GlycoMimetics Receives $15 Million Payment from Pfizer in Connection with Planned Initiation of Phase 3 Trial 4:01 p.m. May 20, 2014 - BusinessWire - BZX
Statement from Pfizer Inc. 6:41 p.m. May 19, 2014 - BusinessWire - BZX
Senesco Completes Acquisition of Fabrus 8:31 a.m. May 19, 2014 - BusinessWire - BZX
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index 8:05 a.m. May 19, 2014 - GlobeNewswire
Pfizer Makes Final Proposal to AstraZeneca 5:03 p.m. May 18, 2014 - BusinessWire - BZX
Pfizer To Submit Palbociclib New Drug Application With FDA Based On Final Results Of PALOMA-1 12:12 p.m. May 16, 2014 - BusinessWire - BZX
FDA Approvals, Stock Price Updates, and Financial Results Release - Analyst Notes on Pfizer, Actavis, Pharmacyclics, Mallinckrodt and Salix Pharmaceuticals 7:40 a.m. May 16, 2014 - PR Newswire - PRF
Exosomes Common Link in Cancer Drug Development 2:18 p.m. May 15, 2014 - ACCESSWIRE
American College of Physicians, CECity, and Pfizer collaborate to increase adult immunization rates 11:27 a.m. May 15, 2014 - PR Newswire - PRF
GlycoMimetics Announces Presentation of Rivipansel Data in Pediatric Patients at American Society of Pediatric Hematology Oncology 27th Annual Meeting 9:03 a.m. May 15, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

European Doctors Explore Chinese Aesthetic Innovations

Pioneering Exchange in Regenerative Aesthetics Ever seen European doctors flocking to China to learn about beauty techniques? That's the scene as aphranel®, the brainchild of MOYOM Biotech, ushers in a week-long clinical exchange under 'The Norns' Weave.' The whole deal aims to unravel how Chinese practices could shape Europe's aesthetic landscape. Yep, it's all about...

The Sift: Slickdeals’ Game-Changing Black Friday Tool

Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...

Cousins Lobster Hits Arkansas for Tasty Pop-Up Tour

A New England Delicacy Rolling into Arkansas Folks in Northwest Arkansas are about to get a bite of the coast, and it's a big deal for any foodie out there who craves that authentic, no-frills lobster experience. Cousins Maine Lobster is setting out on a pop-up tour—a whirlwind of five days from November 11-15—bringing their joy-inducing lobster rolls straight from...

Reducto Office Transforms Document Editing with AI

AI Meets Full-Fidelity Document Editing Gone are the days when AI could only analyze documents. With Reducto Office's latest plugin, the AI's stepping right into the editing game. For free, they say! Built smack-dab into ChatGPT and Codex, this plugin lets users work their AI magic on Word docs, PowerPoint presentations, and Excel spreadsheets. And the kicker? You can see...

Lecanemab's New Data: What Investors Should Monitor

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...

Jewelry Repair and Resizing Demystified by Expert

The Magic of Fixing Sparkles When it comes to keeping those sparkly trinkets as charming as ever, nothing beats a well-timed fix-up. Jewelry repair isn’t just about patching up old necklaces or battered rings; it’s an art of bringing worn-out pieces back to life. I’m talking about the sort of work that Mike Littlejohn at Carbaugh Jewelers breaks down in a recent...

Systemair Shakes Things Up: Closing Netherlands Facility

Systemair's Shocking Shutdown Decision Feels like we're strapped into a roller coaster with these HVAC companies lately. Systemair (NASDAQ Stockholm: SYSR) sure gave us quite the surprise ride by announcing they're pulling the plug on their production facility in Waalwijk, the Netherlands. This isn't just a ripple in a pond; it's a splash that might make some waves in the...

Abel Leads PRSA Maryland Chesapeake as New Chapter President

New Leadership and Opportunities in the PR Landscape Amid all the hustle and bustle of the corporate world, something big's brewing in Baltimore's public relations sphere. Greg Abel, the go-getting mastermind behind Abel Communications, has taken the helm of the newly formed PRSA Maryland Chesapeake chapter. This isn't just about shifting chairs or fancy titles—this...

Air Force Officer's Pretrial Solitary Challenged

High Stakes at Joint Base Anacostia-Bolling Let's get real, the courtroom showdown set for November 17 over at Joint Base Anacostia-Bolling isn’t just another blip on the radar. We're talking about Major Jason P. Watson, a seasoned Air Force officer with an unblemished track record and more tours than most folks care to count. Monument Legal is at his side, hammering at...

Vuzix to Reveal Q3 2026 Results in Upcoming Call

Vuzix Sets the Stage for Its Q3 2026 Earnings Call Out of all the snazzy tech plays you scribble down on a placemat over morning coffee, Vuzix Corporation (NASDAQ: VUZI) is gearing up for some spotlight action. This November 12, at 4:30 PM Eastern Time, they’re unveiling their third quarter 2026 earnings results, piping hot through a conference call. It's the kind of...